About Mahzi Therapeutics
Mahzi Therapeutics is a private company based in South San Francisco, California, incorporated in 2020 in Delaware. It has reported $52,586,424 raised in one offering on Form D since October 2021. Its chief executive is Yael Weiss.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 7, 2021 | Oct 21, 2021amended Jul 8, 2024 | $52,586,424fully sold | 11 | $4.7M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mahzi Therapeutics's Form D filed Jul 8, 2024.
CS
Camille Samuels
Director
SS
Shalini Sharp
Director
SF
Stephen Farr
Director
MS
Marten Steen
Director
YW
Yael Weiss
Chief Executive Officer and director